Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoprolol versus magnesium for prevention of atrial fibrillation after CABG
IRCT2016031520258N5Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Apr 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of metoprolol and magnesium in Atrial fibrillation (AFib) (2 arms), sponsored by Arak University of Medical Sciences. Started Apr 2016; status: completed.
02
Drugs
metoprololmagnesium
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on IRCT2016031520258N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016031520258N5.